Singer A J, Thode H C, Peacock W F. A retrospective study of emergency department potassium disturbances: severity, treatment, and outcomes[J]. Clin Exp Emerg Med, 2017, 4(2):73-79.
[2]
Aggarwal S, Topaloglu H, Kumar S. Trends in emergency room visits due to hyperkalemia in the United States[J]. Value Health, 2015, 18(7): A386.
[3]
Krogager M L, Torp C, Mortensen R N, et al. Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data[J]. Eur Heart J, 2017, 38(2):104-112.
[4]
Hoppe L K, Muhlack D C, Koenig W, et al. Association of abnormal serum potassium levels with arrhythmias and cardiovascular mortality: a systematic review and meta-analysis of observational studies[J]. Cardiovasc Drugs Ther, 2018, 32(2):197-212.
[5]
Christina B,Yuanchao Z, Samuel A S, et al. Acute kidney injury due to diarrheal illness requiring hospitalization: data from the national inpatient sample[J]. J Gen Intern Med, 2018, 33(9):1520-1527.
[6]
Svenja R, Emanuel P, Georg C F, et al. Dyskalemias in patients with acute kidney injury presenting to the emergency department are common and independent predictors of adverse outcome[J]. Int J Clin Pract,2021,75(1):e13653.
[7]
Formiga F, Chivite D, Corbella X, et al. RICA investigators group. influence of potassium levels on one-year outcomes in elderly patients with acute heart failure[J]. Eur J Intern Med, 2019, 60:24-30.
[8]
Einhorn L M, Zhan M, Hsu V D, et al. The frequency of hyperkalemia and its significance in chronic kidney disease[J].Arch Intern Med, 2009, 169(12):1156-1162.
[9]
Peacock W F, Rafique Z, Clark C L, et al. REVEAL-ED study investigators. real world evidence for treatment of hyperkalemia in the emergency department (reveal-ed): a multicenter, prospective, observational study[J]. J Emerg Med, 2018, 55(6):741-750.
[10]
Montague B T, Ouellette J R, Buller G K. Retrospective review of the frequency of ECG changes in hyperkalemia[J]. Clin J Am Soc Nephrol, 2008, 3(2): 324-330.
[11]
Montford J R, Linas S. How dangerous is hyperkalemia? [J]. J Am Soc Nephrol, 2017, 28(11):3155-3165.
[12]
Harel Z, Harel S, Shah P S, et al. Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review[J]. Am J Med, 2013, 126(3):264.e9-26424.
[13]
Almulhim A S, Hall E, Mershid A R, et al. Sodium polystyrene sulfonate induced intestinal necrosis; a case report[J].Saudi Pharm J, 2018, 26(6):771-774.
2022, Vol. 33 
